Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Itron (ITRI) Research & Development (2016 - 2026)

Itron filings provide 18 years of Research & Development readings, the most recent being $55.0 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 9.8% to $55.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $132.8 million, a 37.56% decrease, with the full-year FY2025 number at $207.0 million, down 3.72% from a year prior.
  • Research & Development hit $55.0 million in Q1 2026 for Itron, up from $53.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $58.3 million in Q4 2024 to a low of $12.3 million in Q3 2025.
  • Median Research & Development over the past 5 years was $51.2 million (2024), compared with a mean of $46.6 million.
  • Biggest five-year swings in Research & Development: rose 18.88% in 2023 and later plummeted 76.51% in 2025.
  • Itron's Research & Development stood at $46.6 million in 2022, then grew by 15.64% to $53.9 million in 2023, then grew by 8.2% to $58.3 million in 2024, then fell by 8.97% to $53.1 million in 2025, then rose by 3.56% to $55.0 million in 2026.
  • The last three reported values for Research & Development were $55.0 million (Q1 2026), $53.1 million (Q4 2025), and $12.3 million (Q3 2025) per Business Quant data.